Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization
- 26 November 2002
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 16 (12) , 2395-2399
- https://doi.org/10.1038/sj.leu.2402734
Abstract
Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.Keywords
This publication has 16 references indexed in Scilit:
- Gene expression changes in blood after phlebotomy: implications for gene expression profilingBlood, 2002
- Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous LeukemiaNew England Journal of Medicine, 2002
- Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 casesLeukemia, 2002
- Minimal residual disease in leukaemia patientsThe Lancet Oncology, 2001
- Quality assurance in RT-PCR-based BCR/ABL diagnostics – results of an interlaboratory test and a standardization approachLeukemia, 2000
- Detection and quantification of residual disease in chronic myelogenous leukemiaLeukemia, 2000
- Evaluation of RNA Isolation Methods and Reference Genes for RT-PCR Analyses of Rare Target RNAcclm, 2000
- Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual diseaseLeukemia, 1999
- Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCRLeukemia, 1999
- Minimal Residual Disease after Bone Marrow Transplant for Chronic Myeloid Leukaemia Detected by the Polymerase Chain ReactionLeukemia & Lymphoma, 1993